Document Detail

Multiple stent fractures at the site of coronary artery bypass insertion.
MedLine Citation:
PMID:  19089946     Owner:  NLM     Status:  MEDLINE    
Drug eluting stents have led to a substantial reduction of in-stent restenosis. Stent fracture (SF) is an important cause for the cases of restenosis which still occur. Sites of increased vessel movement, long stents, and overlapping stents have been observed to be more prone to fracture. We report the case of a patient with multiple drug eluting SFs at the site of coronary artery bypass insertion. The decision to implant stents at the site of bypass insertion should be made carefully. SF should be considered when gaps between previously implanted stents are observed.
Holger Hetterich; Johannes Rieber
Related Documents :
17671956 - Prospective randomized study of the restenotic process in small coronary arteries using...
19901426 - Complex intervention of an in-stent restenosis of ostial right coronary artery stent pr...
24037356 - Brazilian adaptation of the questionnaire to assess adherence to treatment for arterial...
12909076 - Contrast media as carriers for local drug delivery. successful inhibition of neointimal...
6407696 - Electrocardiographic chest wall mapping in the diagnosis of coronary artery disease.
11932366 - Failure of prolonged dilation to improve long-term patency of femoropopliteal artery an...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  73     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-24     Completed Date:  2009-02-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  84-7     Citation Subset:  IM    
Copyright Information:
(c) 2008 Wiley-Liss, Inc.
Department of Cardiology, Medizinische Poliklinik, Ludwig-Maximilians University, Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects,  instrumentation*
Cardiovascular Agents / administration & dosage
Coronary Angiography
Coronary Artery Bypass*
Coronary Restenosis / etiology,  radiography,  therapy*
Coronary Stenosis / radiography,  surgery*
Drug-Eluting Stents*
Middle Aged
Prosthesis Design
Prosthesis Failure*
Risk Factors
Sirolimus / administration & dosage
Treatment Outcome
Reg. No./Substance:
0/Cardiovascular Agents; 53123-88-9/Sirolimus
Comment In:
Catheter Cardiovasc Interv. 2009 Jan 1;73(1):88-9   [PMID:  19089948 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High pressure reveals structural determinants for globin hexacoordination: neuroglobin and myoglobin...
Next Document:  Natural history of the E1-like superfamily: implication for adenylation, sulfur transfer, and ubiqui...